Paper Details

  1. Home
  2. Paper Details

Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France.

Author: BoissonnasAlain, NabetNorbert, VaresconIsabelle, Vidal-TrecanGwenaëlle

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

To decrease buprenorphine injection, prescribers should participate in networks with specialized centers, and social and professional rehabilitation programs should be implemented for subjects on buprenorphine maintenance therapy.
Paper Details　
Original Abstract of the Article :
BACKGROUND: In 1996, sublingual buprenorphine was authorized for prescription in France for maintenance therapy (MT). MT should facilitate the rehabilitation of opioid-dependent drug users and reduce the risks associated with injection. However, misuse and side effects have been reported. OBJECTIVE...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0376-8716(02)00312-5

データ提供：米国国立医学図書館（NLM）

Intravenous Use of Buprenorphine in Drug Users

Buprenorphine is a medication used for opioid maintenance therapy (MT), helping individuals manage their opioid dependency. This study investigated the intravenous use of buprenorphine tablets by drug users receiving MT in France. It's like studying the different ways a desert traveler might choose to access a precious water source.

Intravenous Misuse of Buprenorphine

The study found that a significant proportion of patients receiving buprenorphine MT had injected the medication, despite its intended sublingual administration. This highlights the importance of addressing the potential for misuse and diversion of this medication. It's like ensuring that the water source is well-protected to prevent overuse or contamination.

Addressing Misuse and Diversion

This research highlights the need for improved strategies to prevent intravenous misuse of buprenorphine. It's like building a stronger fence around the oasis to ensure that everyone benefits from the water source. Implementing better monitoring and education programs could help to reduce the risk of misuse and ensure that buprenorphine is used safely and effectively.

Dr.Camel's Conclusion

This study emphasizes the importance of safeguarding medication and ensuring its appropriate use. It's a reminder that we must vigilantly protect the vital resources that are available to us, ensuring that they are used responsibly and benefit everyone.

Date :
  1. Date Completed 2003-07-09
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

12609698

DOI: Digital Object Identifier

10.1016/s0376-8716(02)00312-5

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.